1 |
Leikin SL. Immunobiology of histiocytosis-X. Hematol Oncol Clin North Am. 1987;1:49-61.
|
2 |
Ryu Y, Lee H, Lee S, et al. Pathological characteristics of 20 cases of langerhans cell histiocytosis and specificity of immunohistochemical stain of langerin (CD207). Korean J Pathol. 2009;43:113-9.
DOI
|
3 |
Park BM, Shin KH, Kim HW, Kim HJ. Treatment of langerhans cell histiocytosis. J Korean Orthop Assoc. 1996;31:1218-27.
|
4 |
Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157-66.
DOI
ScienceOn
|
5 |
Hicks J, Flaitz CM. Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(2 Suppl):S42-66.
DOI
ScienceOn
|
6 |
Seo JJ. Recent advances in histiocytic disorders. Korean J Pediatr. 2007;50:524-30.
DOI
|
7 |
Lampert F. Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am. 1998;12:213-9.
DOI
|
8 |
Komp DM. Historical perspectives of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1987;1:9-21.
|
9 |
Lichtenstein L. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol. 1953;56:84-102.
|
10 |
Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999;85:2278-90.
DOI
ScienceOn
|
11 |
Leonidas JC, Guelfguat M, Valderrama E. Langerhans' cell histiocytosis. Lancet. 2003;361:1293-5.
DOI
ScienceOn
|
12 |
Islinger RB, Kuklo TR, Owens BD, et al. Langerhans' cell histiocytosis in patients older than 21 years. Clin Orthop Relat Res. 2000;(379):231-5.
|
13 |
Yasko AW, Fanning CV, Ayala AG, Carrasco CH, Murray JA. Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone). J Bone Joint Surg Am. 1998;80:219-28.
DOI
|
14 |
Han I, Suh ES, Lee SH, Cho HS, Oh JH, Kim HS. Management of eosinophilic granuloma occurring in the appendicular skeleton in children. Clin Orthop Surg. 2009;1:63-7.
DOI
|
15 |
Capanna R, Springfield DS, Ruggieri P, et al. Direct cortisone injection in eosinophilic granuloma of bone: a preliminary report on 11 patients. J Pediatr Orthop. 1985;5:339-42.
DOI
|
16 |
Egeler RM, Thompson RC Jr, Voute PA, Nesbit ME Jr. Intralesional infiltration of corticosteroids in localized Langerhans' cell histiocytosis. J Pediatr Orthop. 1992;12:811-4.
DOI
|
17 |
Scaglietti O, Marchetti PG, Bartolozzi P. Final results obtained in the treatment of bone cysts with methylprednisolone acetate (depo-medrol) and a discussion of results achieved in other bone lesions. Clin Orthop Relat Res. 1982;(165):33-42.
|
18 |
Arenzana-Seisdedos F, Barbey S, Virelizier JL, Kornprobst M, Nezelof C. Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J Clin Invest. 1986;77:326-9.
DOI
|
19 |
Marusic A, Raisz LG. Cortisol modulates the actions of interleukin-1 alpha on bone formation, resorption, and prostaglandin production in cultured mouse parietal bones. Endocrinology. 1991;129:2699-706.
DOI
ScienceOn
|
20 |
Chung YG, Kim YS, Rhee SK, et al. Langerhans' cell histiocytosis in patients younger than 2 years. J Korean Orthop Assoc. 2006;41:37-42.
DOI
|
21 |
Cohen M, Zornoza J, Cangir A, Murray JA, Wallace S. Direct injection of methylprednisolone sodium succinate in the treatment of solitary eosinophilic granuloma of bone: a report of 9 cases. Radiology. 1980;136:289-93.
DOI
|
22 |
Lichtenstein L. Histiocytosis X (eosinophilic granuloma of bone, letterer-siwe disease, and schueller-christian disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am. 1964;46:76-90.
DOI
|